SIMILAR PATTERNS OF AMINO ACIDS FOR 3LZU_A_017A200

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1b4e PROTEIN
(5-AMINOLEVULINIC
ACID DEHYDRATASE)


(Escherichia
coli)
PF00490
(ALAD)
5 GLY A 305
ALA A 306
ASP A 307
ILE A 255
ILE A 301
None
0.84A 3lzuA-1b4eA:
undetectable
3lzuA-1b4eA:
13.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1czi CHYMOSIN

(Bos taurus)
PF00026
(Asp)
5 LEU E  30
ASP E  32
GLY E  34
ASP E  37
ILE E 120
None
0.66A 3lzuA-1cziE:
6.8
3lzuA-1cziE:
17.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fob BETA-1,4-GALACTANASE

(Aspergillus
aculeatus)
PF07745
(Glyco_hydro_53)
5 GLY A  40
ALA A  39
ASP A  38
PRO A 299
ILE A 328
None
0.88A 3lzuA-1fobA:
undetectable
3lzuA-1fobA:
15.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
VAL A  82
ILE A  84
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 ( 4.9A)
A79  A 800 ( 4.4A)
A79  A 800 ( 3.9A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.55A 3lzuA-1hvcA:
13.7
3lzuA-1hvcA:
45.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.0A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 4.7A)
A79  A 800 ( 4.3A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.42A 3lzuA-1hvcA:
13.7
3lzuA-1hvcA:
45.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
VAL A  82
ILE A  84
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.9A)
A79  A 800 ( 4.4A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.46A 3lzuA-1hvcA:
13.7
3lzuA-1hvcA:
45.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kae HISTIDINOL
DEHYDROGENASE


(Escherichia
coli)
PF00815
(Histidinol_dh)
5 GLY A 227
ALA A 228
ASP A 204
GLY A 196
ILE A 206
None
0.81A 3lzuA-1kaeA:
undetectable
3lzuA-1kaeA:
12.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1l3i PRECORRIN-6Y
METHYLTRANSFERASE/PU
TATIVE DECARBOXYLASE


(Methanothermobacter
thermautotrophicus)
PF13847
(Methyltransf_31)
5 LEU A 136
GLY A 108
VAL A 179
GLY A  15
ILE A 135
None
SAH  A 801 (-3.4A)
None
SAH  A 801 ( 3.8A)
None
0.86A 3lzuA-1l3iA:
undetectable
3lzuA-1l3iA:
19.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1lk5 D-RIBOSE-5-PHOSPHATE
ISOMERASE


(Pyrococcus
horikoshii)
PF06026
(Rib_5-P_isom_A)
5 GLY A 101
ALA A 102
GLY A 207
ILE A  97
ILE A 179
CL  A1001 (-3.4A)
None
None
None
None
0.89A 3lzuA-1lk5A:
undetectable
3lzuA-1lk5A:
19.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
None
0.53A 3lzuA-1q9pA:
9.7
3lzuA-1q9pA:
87.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.45A 3lzuA-1sivA:
18.9
3lzuA-1sivA:
50.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1u2e 2-HYDROXY-6-KETONONA
-2,4-DIENEDIOIC ACID
HYDROLASE


(Escherichia
coli)
PF12697
(Abhydrolase_6)
5 LEU A 281
GLY A  61
ALA A  60
ILE A  54
VAL A 277
None
0.84A 3lzuA-1u2eA:
undetectable
3lzuA-1u2eA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1v5f PYRUVATE OXIDASE

(Aerococcus
viridans)
PF00205
(TPP_enzyme_M)
PF02775
(TPP_enzyme_C)
PF02776
(TPP_enzyme_N)
5 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.95A 3lzuA-1v5fA:
undetectable
3lzuA-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wsv AMINOMETHYLTRANSFERA
SE


(Homo sapiens)
PF01571
(GCV_T)
PF08669
(GCV_T_C)
5 LEU A 152
VAL A 192
GLY A 166
VAL A 207
ILE A 205
LEU  A 152 ( 0.6A)
VAL  A 192 ( 0.6A)
GLY  A 166 ( 0.0A)
VAL  A 207 ( 0.6A)
ILE  A 205 ( 0.4A)
0.79A 3lzuA-1wsvA:
undetectable
3lzuA-1wsvA:
14.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xtz RIBOSE-5-PHOSPHATE
ISOMERASE


(Saccharomyces
cerevisiae)
PF06026
(Rib_5-P_isom_A)
5 GLY A 123
ALA A 124
GLY A 235
ILE A 119
ILE A 207
None
0.93A 3lzuA-1xtzA:
undetectable
3lzuA-1xtzA:
17.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bc0 NADH OXIDASE

(Streptococcus
pyogenes)
PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2)
5 GLY A 453
ALA A 454
ASP A 456
ILE A 387
ILE A 426
None
0.61A 3lzuA-2bc0A:
undetectable
3lzuA-2bc0A:
13.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cvj THIOREDOXIN
REDUCTASE RELATED
PROTEIN


(Thermus
thermophilus)
PF00890
(FAD_binding_2)
PF07992
(Pyr_redox_2)
5 LEU A 170
GLY A  24
ALA A  23
ASP A 177
VAL A 164
None
0.93A 3lzuA-2cvjA:
undetectable
3lzuA-2cvjA:
20.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dph FORMALDEHYDE
DISMUTASE


(Pseudomonas
putida)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
6 GLY A 174
ALA A 201
VAL A 189
GLY A 296
ILE A 297
ILE A 191
None
1.46A 3lzuA-2dphA:
undetectable
3lzuA-2dphA:
15.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
0.51A 3lzuA-2fmbA:
15.0
3lzuA-2fmbA:
34.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2g28 PYRUVATE
DEHYDROGENASE E1
COMPONENT


(Escherichia
coli)
PF00456
(Transketolase_N)
5 LEU A 565
GLY A 573
PRO A 594
VAL A 516
ILE A 518
None
0.79A 3lzuA-2g28A:
undetectable
3lzuA-2g28A:
8.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2g4r MOLYBDOPTERIN
BIOSYNTHESIS MOG
PROTEIN


(Mycobacterium
tuberculosis)
PF00994
(MoCF_biosynth)
5 GLY A 115
ASP A  97
GLY A 118
ILE A 125
ILE A  99
None
TRS  A 301 (-2.8A)
None
None
None
0.85A 3lzuA-2g4rA:
undetectable
3lzuA-2g4rA:
22.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gzl 2-C-METHYL-D-ERYTHRI
TOL
2,4-CYCLODIPHOSPHATE
SYNTHASE


(Escherichia
coli)
PF02542
(YgbB)
5 GLY A  37
ASP A   8
GLY A 145
PRO A 103
ILE A  20
None
ZN  A 900 ( 2.4A)
None
None
None
0.96A 3lzuA-2gzlA:
undetectable
3lzuA-2gzlA:
24.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2h00 METHYLTRANSFERASE 10
DOMAIN CONTAINING
PROTEIN


(Homo sapiens)
PF05971
(Methyltransf_10)
5 GLY A  84
ALA A  85
GLY A  69
VAL A 120
ILE A 118
None
None
None
DTU  A2140 (-4.0A)
None
0.98A 3lzuA-2h00A:
undetectable
3lzuA-2h00A:
18.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p2s PUTATIVE
OXIDOREDUCTASE


(Pectobacterium
atrosepticum)
PF01408
(GFO_IDH_MocA)
PF02894
(GFO_IDH_MocA_C)
5 LEU A 250
GLY A 136
ALA A 135
ILE A 127
ILE A 261
None
0.96A 3lzuA-2p2sA:
undetectable
3lzuA-2p2sA:
18.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p4z METAL-DEPENDENT
HYDROLASES OF THE
BETA-LACTAMASE
SUPERFAMILY II


(Caldanaerobacter
subterraneus)
PF00753
(Lactamase_B)
5 LEU A  38
GLY A 145
ILE A 149
VAL A  47
ILE A  45
None
0.92A 3lzuA-2p4zA:
undetectable
3lzuA-2p4zA:
15.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ph3 3-OXOACYL-[ACYL
CARRIER PROTEIN]
REDUCTASE


(Thermus
thermophilus)
PF13561
(adh_short_C2)
5 LEU A  28
GLY A  14
ALA A   9
VAL A  56
ILE A  30
None
0.98A 3lzuA-2ph3A:
undetectable
3lzuA-2ph3A:
19.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ri6 2-HYDROXY-6-OXO-6-PH
ENYLHEXA-2,4-DIENOAT
E HYDROLASE


(Paraburkholderia
xenovorans)
PF12697
(Abhydrolase_6)
5 LEU A 283
GLY A  63
ALA A  62
VAL A 279
ILE A 280
None
0.85A 3lzuA-2ri6A:
undetectable
3lzuA-2ri6A:
15.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.9A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.8A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-4.2A)
AB1  A 501 ( 4.2A)
0.36A 3lzuA-2rkfA:
20.8
3lzuA-2rkfA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rsp RSV PROTEASE

(Rous sarcoma
virus)
PF00077
(RVP)
6 LEU A  35
ASP A  37
GLY A  39
ALA A  40
ASP A  41
ILE A 108
None
0.48A 3lzuA-2rspA:
12.8
3lzuA-2rspA:
33.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wsk GLYCOGEN DEBRANCHING
ENZYME


(Escherichia
coli)
PF00128
(Alpha-amylase)
PF02922
(CBM_48)
5 LEU A 188
GLY A 255
ALA A 254
ILE A 248
ILE A 185
None
0.77A 3lzuA-2wskA:
undetectable
3lzuA-2wskA:
8.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ww9 SEC SIXTY-ONE
PROTEIN HOMOLOG


(Saccharomyces
cerevisiae)
PF00344
(SecY)
PF10559
(Plug_translocon)
5 GLY A  40
ALA A  39
VAL A 170
ILE A  33
ILE A 171
None
0.96A 3lzuA-2ww9A:
undetectable
3lzuA-2ww9A:
11.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3aqp PROBABLE SECDF
PROTEIN-EXPORT
MEMBRANE PROTEIN


(Thermus
thermophilus)
PF02355
(SecD_SecF)
PF07549
(Sec_GG)
5 GLY A 327
ALA A 329
GLY A 274
ILE A 271
VAL A 693
None
0.89A 3lzuA-3aqpA:
undetectable
3lzuA-3aqpA:
9.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3b8b CYSQ, SULFITE
SYNTHESIS PATHWAY
PROTEIN


(Bacteroides
thetaiotaomicron)
PF00459
(Inositol_P)
6 ALA A   6
ASP A   5
VAL A 112
GLY A  11
ILE A  14
ILE A 100
None
1.33A 3lzuA-3b8bA:
undetectable
3lzuA-3b8bA:
16.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3c4n UNCHARACTERIZED
PROTEIN DR_0571


(Deinococcus
radiodurans)
PF01266
(DAO)
5 LEU A 370
GLY A 200
VAL A  40
VAL A 230
ILE A 228
None
0.84A 3lzuA-3c4nA:
undetectable
3lzuA-3c4nA:
11.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3d43 SPHERICASE

(Lysinibacillus
sphaericus)
PF00082
(Peptidase_S8)
5 ALA A  97
ASP A  96
GLY A  92
PRO A 254
ILE A  30
None
0.95A 3lzuA-3d43A:
undetectable
3lzuA-3d43A:
16.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dbg PUTATIVE CYTOCHROME
P450


(Streptomyces
coelicolor)
PF00067
(p450)
5 GLY A 359
ALA A 360
ASP A 361
PRO A  24
ILE A 356
None
0.85A 3lzuA-3dbgA:
undetectable
3lzuA-3dbgA:
10.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gf7 GLUTACONYL-COA
DECARBOXYLASE
SUBUNIT A


([Clostridium]
symbiosum)
PF01039
(Carboxyl_trans)
5 LEU A 148
GLY A 191
ALA A 213
GLY A 256
ILE A 189
None
0.79A 3lzuA-3gf7A:
undetectable
3lzuA-3gf7A:
11.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hdy UDP-GALACTOPYRANOSE
MUTASE


(Deinococcus
radiodurans)
PF03275
(GLF)
PF13450
(NAD_binding_8)
5 GLY A  38
ALA A  37
VAL A 237
VAL A  55
ILE A  57
FAD  A 450 (-3.3A)
None
None
None
None
0.88A 3lzuA-3hdyA:
undetectable
3lzuA-3hdyA:
12.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hh1 TETRAPYRROLE
METHYLASE FAMILY
PROTEIN


(Chlorobaculum
tepidum)
PF00590
(TP_methylase)
5 LEU A  79
GLY A 111
ALA A 110
VAL A  75
ILE A  76
None
0.89A 3lzuA-3hh1A:
undetectable
3lzuA-3hh1A:
22.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jv7 ADH-A

(Rhodococcus
ruber)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 LEU A 211
GLY A 216
ALA A 217
ASP A 218
ILE A 190
None
0.67A 3lzuA-3jv7A:
undetectable
3lzuA-3jv7A:
14.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kl7 PUTATIVE
METAL-DEPENDENT
HYDROLASE


(Parabacteroides
distasonis)
PF13483
(Lactamase_B_3)
5 LEU A 156
GLY A 153
ASP A 120
ILE A  77
ILE A 130
None
0.92A 3lzuA-3kl7A:
undetectable
3lzuA-3kl7A:
16.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kyh MRNA-CAPPING ENZYME
SUBUNIT BETA


(Saccharomyces
cerevisiae)
PF02940
(mRNA_triPase)
5 ALA A 337
ASP A 336
ASP A 315
VAL A 322
ILE A 313
None
0.97A 3lzuA-3kyhA:
undetectable
3lzuA-3kyhA:
15.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lun ULILYSIN

(Methanosarcina
acetivorans)
PF05572
(Peptidase_M43)
5 ALA A 209
ASP A 207
VAL A 175
ILE A  93
ILE A 205
None
0.99A 3lzuA-3lunA:
undetectable
3lzuA-3lunA:
15.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  48
None
0.77A 3lzuA-3mwsA:
20.2
3lzuA-3mwsA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
PRO A  81
VAL A  82
ILE A  84
None
0.42A 3lzuA-3mwsA:
20.2
3lzuA-3mwsA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
None
0.21A 3lzuA-3mwsA:
20.2
3lzuA-3mwsA:
78.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3p4g ANTIFREEZE PROTEIN

(Marinomonas
primoryensis)
no annotation 5 ASP A 103
GLY A  99
ALA A  98
VAL A 124
GLY A 137
CA  A 403 ( 2.4A)
CA  A 403 (-4.1A)
CA  A 404 (-4.5A)
None
CA  A 405 (-4.1A)
0.98A 3lzuA-3p4gA:
undetectable
3lzuA-3p4gA:
14.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3s8m ENOYL-ACP REDUCTASE

(Xanthomonas
oryzae)
PF07055
(Eno-Rase_FAD_bd)
PF12241
(Enoyl_reductase)
PF12242
(Eno-Rase_NADH_b)
5 GLY A 213
ALA A 212
ILE A 206
VAL A 121
ILE A 122
None
0.84A 3lzuA-3s8mA:
undetectable
3lzuA-3s8mA:
14.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3slz GAG-PRO-POL
POLYPROTEIN


(Murine leukemia
virus)
PF00077
(RVP)
5 ASP A  32
GLY A  34
ALA A  35
VAL A  39
PRO A  89
3TL  A 126 (-2.4A)
3TL  A 126 (-3.1A)
3TL  A 126 ( 4.0A)
None
3TL  A 126 (-4.0A)
0.54A 3lzuA-3slzA:
11.2
3lzuA-3slzA:
25.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3slz GAG-PRO-POL
POLYPROTEIN


(Murine leukemia
virus)
PF00077
(RVP)
6 LEU A  30
ASP A  32
GLY A  34
ALA A  35
VAL A  39
GLY A  56
None
3TL  A 126 (-2.4A)
3TL  A 126 (-3.1A)
3TL  A 126 ( 4.0A)
None
3TL  A 126 (-3.4A)
0.48A 3lzuA-3slzA:
11.2
3lzuA-3slzA:
25.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
SO4  A 101 (-4.2A)
017  A 201 (-2.6A)
017  A 201 (-3.5A)
017  A 201 (-4.2A)
017  A 201 (-4.0A)
017  A 201 (-3.3A)
1.25A 3lzuA-3t3cA:
19.4
3lzuA-3t3cA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
SO4  A 101 (-4.2A)
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.5A)
017  A 201 (-3.5A)
017  A 201 (-4.2A)
None
017  A 201 (-4.0A)
017  A 201 (-3.3A)
None
0.62A 3lzuA-3t3cA:
19.4
3lzuA-3t3cA:
79.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tl2 MALATE DEHYDROGENASE

(Bacillus
anthracis)
PF00056
(Ldh_1_N)
PF02866
(Ldh_1_C)
5 LEU A  40
ASP A  36
GLY A  12
ILE A  85
ILE A  37
None
EDO  A 315 (-3.3A)
EDO  A 315 ( 4.1A)
None
None
0.79A 3lzuA-3tl2A:
undetectable
3lzuA-3tl2A:
15.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
017  A 201 (-2.6A)
017  A 201 (-3.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
017  A 201 (-4.6A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
017  A 201 (-4.1A)
017  A 201 (-4.7A)
0.31A 3lzuA-3ttpA:
20.3
3lzuA-3ttpA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
None
017  A 202 ( 2.5A)
017  A 201 (-3.4A)
017  A 201 ( 4.0A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
1.27A 3lzuA-3u7sA:
19.6
3lzuA-3u7sA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
None
017  A 202 ( 2.5A)
017  A 201 ( 3.5A)
017  A 201 (-3.4A)
017  A 201 (-3.2A)
017  A 201 ( 4.0A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
017  A 202 (-4.0A)
0.39A 3lzuA-3u7sA:
19.6
3lzuA-3u7sA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3uhl PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
None
0.40A 3lzuA-3uhlA:
16.3
3lzuA-3uhlA:
80.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4g09 HISTIDINOL
DEHYDROGENASE


(Brucella suis)
PF00815
(Histidinol_dh)
6 LEU A 240
ALA A 243
ASP A 244
GLY A 352
ILE A 351
ILE A 241
None
1.31A 3lzuA-4g09A:
undetectable
3lzuA-4g09A:
12.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gbr BETA-2 ADRENERGIC
RECEPTOR


(Homo sapiens)
PF00001
(7tm_1)
5 VAL A  44
GLY A  90
ILE A  94
VAL A  39
ILE A  43
None
0.97A 3lzuA-4gbrA:
undetectable
3lzuA-4gbrA:
13.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gmk RIBOSE-5-PHOSPHATE
ISOMERASE A


(Lactobacillus
salivarius)
PF06026
(Rib_5-P_isom_A)
5 GLY A 100
ALA A 101
GLY A 204
ILE A  96
ILE A 176
PO4  A 301 (-3.6A)
None
None
None
None
0.96A 3lzuA-4gmkA:
undetectable
3lzuA-4gmkA:
17.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4inj LMO1638 PROTEIN

(Listeria
monocytogenes)
PF02016
(Peptidase_S66)
5 LEU A 162
ALA A 309
GLY A 306
ILE A 305
ILE A 321
None
0.89A 3lzuA-4injA:
undetectable
3lzuA-4injA:
16.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jlw GLUTATHIONE-INDEPEND
ENT FORMALDEHYDE
DEHYDROGENASE


(Pseudomonas
aeruginosa)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
6 GLY A 175
ALA A 202
VAL A 190
GLY A 298
ILE A 299
ILE A 192
None
1.41A 3lzuA-4jlwA:
undetectable
3lzuA-4jlwA:
14.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4lom IMIDAZOLEGLYCEROL-PH
OSPHATE DEHYDRATASE


(Mycobacterium
tuberculosis)
PF00475
(IGPD)
5 LEU A 165
GLY A  84
ALA A 161
VAL A 116
ILE A 163
None
0.89A 3lzuA-4lomA:
undetectable
3lzuA-4lomA:
19.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4m2j AMINOTRANSFERASE

(Streptomyces
lavendulae)
PF00155
(Aminotran_1_2)
5 GLY A 278
ALA A 281
VAL A 311
GLY A 228
ILE A 200
None
0.97A 3lzuA-4m2jA:
undetectable
3lzuA-4m2jA:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4na3 POLYKETIDE SYNTHASE
PKSJ


(Bacillus
subtilis)
PF00109
(ketoacyl-synt)
PF02801
(Ketoacyl-synt_C)
PF16197
(KAsynt_C_assoc)
5 LEU A 180
GLY A 201
ALA A 200
ILE A  12
ILE A 183
None
0.95A 3lzuA-4na3A:
undetectable
3lzuA-4na3A:
10.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ALA A  28
ASP A  29
ASP A  30
GLY A  48
ILE A  84
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-4.8A)
RIT  A 500 (-4.8A)
RIT  A 500 (-4.3A)
0.79A 3lzuA-4njvA:
20.0
3lzuA-4njvA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
PRO A  81
ILE A  84
None
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-4.8A)
None
RIT  A 500 (-3.9A)
RIT  A 500 (-4.3A)
0.53A 3lzuA-4njvA:
20.0
3lzuA-4njvA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
None
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
RIT  A 500 (-3.9A)
RIT  A 500 (-4.3A)
0.42A 3lzuA-4njvA:
20.0
3lzuA-4njvA:
81.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qlz SJCHGC07024 PROTEIN

(Schistosoma
japonicum)
PF00719
(Pyrophosphatase)
5 LEU A  17
GLY A  20
PRO A  31
VAL A  30
ILE A  24
None
0.80A 3lzuA-4qlzA:
undetectable
3lzuA-4qlzA:
15.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rwe SUGAR-BINDING
TRANSPORT PROTEIN


(Yersinia pestis)
PF13407
(Peripla_BP_4)
5 GLY A 196
ALA A 190
ILE A 223
VAL A 214
ILE A 156
None
None
GOL  A 401 ( 4.2A)
None
None
0.95A 3lzuA-4rweA:
undetectable
3lzuA-4rweA:
19.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rzk SMALL HEAT SHOCK
PROTEIN HSP20 FAMILY


(Sulfolobus
solfataricus)
PF00011
(HSP20)
5 LEU A 121
ALA A  87
ILE A  90
PRO A 139
ILE A 136
None
0.96A 3lzuA-4rzkA:
undetectable
3lzuA-4rzkA:
25.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4tnb G PROTEIN-COUPLED
RECEPTOR KINASE 5


(Homo sapiens)
PF00069
(Pkinase)
PF00615
(RGS)
5 LEU A  45
ASP A  52
GLY A  63
ILE A  62
ILE A  49
None
0.89A 3lzuA-4tnbA:
undetectable
3lzuA-4tnbA:
11.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4x84 RIBOSE-5-PHOSPHATE
ISOMERASE A


(Pseudomonas
aeruginosa)
PF06026
(Rib_5-P_isom_A)
5 GLY A 101
ALA A 102
GLY A 200
ILE A  97
ILE A 172
FLC  A 300 (-3.3A)
None
None
None
None
0.95A 3lzuA-4x84A:
undetectable
3lzuA-4x84A:
19.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
8 LEU A  30
ASP A  32
GLY A  34
ALA A  35
ASP A  36
VAL A  39
GLY A  58
ILE A 100
None
4B1  A 201 (-2.9A)
4B1  A 201 ( 4.6A)
4B1  A 201 (-3.6A)
4B1  A 201 (-4.4A)
None
4B1  A 201 (-3.4A)
4B1  A 201 (-4.8A)
0.58A 3lzuA-4ydfA:
12.9
3lzuA-4ydfA:
32.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4z26 PUTATIVE GMC-TYPE
OXIDOREDUCTASE R135


(Acanthamoeba
polyphaga
mimivirus)
PF00732
(GMC_oxred_N)
PF05199
(GMC_oxred_C)
5 LEU A  36
VAL A 296
ILE A 267
VAL A  10
ILE A  12
None
0.84A 3lzuA-4z26A:
undetectable
3lzuA-4z26A:
9.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b18 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
None
0.43A 3lzuA-5b18A:
17.6
3lzuA-5b18A:
71.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b18 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
None
1.08A 3lzuA-5b18A:
17.6
3lzuA-5b18A:
71.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cw2 PUTATIVE EPOXIDE
HYDROLASE EPHA


(Mycolicibacterium
thermoresistibile)
no annotation 5 LEU C 315
GLY C  53
ALA C  52
ILE C  46
ILE C 312
None
0.82A 3lzuA-5cw2C:
undetectable
3lzuA-5cw2C:
14.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cw5 BRCA1/BRCA2-CONTAINI
NG COMPLEX SUBUNIT 3


(Camponotus
floridanus)
PF01398
(JAB)
5 LEU A  79
VAL A  89
GLY A  33
ILE A  51
ILE A  36
None
0.97A 3lzuA-5cw5A:
undetectable
3lzuA-5cw5A:
14.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5e84 78 KDA
GLUCOSE-REGULATED
PROTEIN


(Homo sapiens)
PF00012
(HSP70)
5 LEU A  35
ASP A 391
VAL A 394
GLY A 226
PRO A 173
None
None
None
ATP  A 801 (-3.3A)
ZN  A 806 ( 4.6A)
0.90A 3lzuA-5e84A:
undetectable
3lzuA-5e84A:
11.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5fmg PROTEASOME, PUTATIVE

(Plasmodium
falciparum)
PF00227
(Proteasome)
5 ASP H 157
VAL H  12
ILE H  37
VAL H 231
ILE H 233
None
0.98A 3lzuA-5fmgH:
undetectable
3lzuA-5fmgH:
14.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5g5g PUTATIVE XANTHINE
DEHYDROGENASE YAGT
IRON-SULFUR-BINDING
SUBUNIT


(Escherichia
coli)
PF00111
(Fer2)
PF01799
(Fer2_2)
5 GLY A 211
ALA A 212
ASP A 154
GLY A 159
ILE A 216
None
None
None
FES  A 230 (-4.2A)
None
0.84A 3lzuA-5g5gA:
undetectable
3lzuA-5g5gA:
26.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5h1k GEM-ASSOCIATED
PROTEIN 5


(Homo sapiens)
PF00400
(WD40)
PF12894
(ANAPC4_WD40)
5 LEU A 157
GLY A 132
VAL A 177
VAL A 167
ILE A 169
None
0.81A 3lzuA-5h1kA:
undetectable
3lzuA-5h1kA:
8.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hs0 ANKYRIN DOMAIN
PROTEIN ANK1C4_7


(synthetic
construct)
PF12796
(Ank_2)
5 LEU A 121
GLY A 126
ALA A 127
ASP A 128
VAL A  86
None
0.97A 3lzuA-5hs0A:
undetectable
3lzuA-5hs0A:
19.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jxk ASP/GLU-SPECIFIC
DIPEPTIDYL-PEPTIDASE


(Porphyromonas
endodontalis)
PF10459
(Peptidase_S46)
5 GLY A 583
ALA A 594
VAL A 263
ILE A 689
ILE A 581
None
0.98A 3lzuA-5jxkA:
undetectable
3lzuA-5jxkA:
8.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
None
1.38A 3lzuA-5t2zA:
21.1
3lzuA-5t2zA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.28A 3lzuA-5t2zA:
21.1
3lzuA-5t2zA:
76.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tky PUTATIVE
UNCHARACTERIZED
PROTEIN


(Chaetomium
thermophilum)
PF00012
(HSP70)
5 LEU A  14
ASP A 370
VAL A 373
GLY A 205
PRO A 150
None
None
None
ATP  A 700 (-3.5A)
None
0.87A 3lzuA-5tkyA:
undetectable
3lzuA-5tkyA:
12.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u2w SHORT CHAIN
DEHYDROGENASE


(Burkholderia
cenocepacia)
PF00106
(adh_short)
5 ALA A 170
ASP A 172
GLY A 164
ILE A 163
VAL A 137
None
0.97A 3lzuA-5u2wA:
undetectable
3lzuA-5u2wA:
17.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ufm METHYLTRANSFERASE
DOMAIN PROTEIN


(Burkholderia
thailandensis)
no annotation 5 ASP A  95
GLY A  76
ASP A  72
VAL A 120
GLY A 136
SAH  A 301 (-2.7A)
SAH  A 301 (-3.6A)
None
SAH  A 301 (-4.1A)
AZ8  A 302 ( 3.5A)
0.83A 3lzuA-5ufmA:
undetectable
3lzuA-5ufmA:
17.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ve3 BPPRF

(Paraburkholderia
phytofirmans)
no annotation 5 GLY B  88
ALA B  89
ASP B  90
VAL B  59
ILE B  80
None
0.80A 3lzuA-5ve3B:
undetectable
3lzuA-5ve3B:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vm2 ALCOHOL
DEHYDROGENASE


(Escherichia
coli)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 GLY A 237
ALA A 238
ASP A 239
VAL A 199
ILE A 173
None
0.91A 3lzuA-5vm2A:
undetectable
3lzuA-5vm2A:
15.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xj1 UNCHARACTERIZED RNA
METHYLTRANSFERASE
SP_1029


(Streptococcus
pneumoniae)
no annotation 5 GLY A 399
ALA A 400
ASP A 401
ILE A 373
ILE A 378
None
0.95A 3lzuA-5xj1A:
undetectable
3lzuA-5xj1A:
14.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6b92 U6 SMALL NUCLEAR RNA
(ADENINE-(43)-N(6))-
METHYLTRANSFERASE


(Homo sapiens)
no annotation 5 GLY A 121
ALA A 122
GLY A 106
VAL A 157
ILE A 155
None
0.98A 3lzuA-6b92A:
undetectable
3lzuA-6b92A:
15.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fiv RETROPEPSIN

(Feline
immunodeficiency
virus)
PF00077
(RVP)
6 LEU A  28
ASP A  30
GLY A  32
ALA A  33
ASP A  34
GLY A  58
None
3TL  A 201 (-3.5A)
3TL  A 201 (-3.4A)
3TL  A 201 (-4.0A)
3TL  A 201 (-3.9A)
3TL  A 201 (-3.4A)
0.17A 3lzuA-6fivA:
15.4
3lzuA-6fivA:
29.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fiv RETROPEPSIN

(Feline
immunodeficiency
virus)
PF00077
(RVP)
6 LEU A  28
ASP A  30
GLY A  32
ALA A  33
ASP A  34
VAL A  99
None
3TL  A 201 (-3.5A)
3TL  A 201 (-3.4A)
3TL  A 201 (-4.0A)
3TL  A 201 (-3.9A)
None
0.45A 3lzuA-6fivA:
15.4
3lzuA-6fivA:
29.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
7 LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
0.69A 3lzuA-6upjA:
18.0
3lzuA-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
7 LEU A  23
ASP A  25
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
None
NIU  A 100 (-2.8A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
0.87A 3lzuA-6upjA:
18.0
3lzuA-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
0.64A 3lzuA-6upjA:
18.0
3lzuA-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
0.78A 3lzuA-6upjA:
18.0
3lzuA-6upjA:
50.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1am5 PEPSIN

(Gadus morhua)
PF00026
(Asp)
6 ASP A 215
GLY A 217
ASP A 303
VAL A 222
VAL A 291
ILE A 300
None
1.28A 3lzuB-1am5A:
7.5
3lzuB-1am5A:
17.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1b4e PROTEIN
(5-AMINOLEVULINIC
ACID DEHYDRATASE)


(Escherichia
coli)
PF00490
(ALAD)
5 GLY A 305
ALA A 306
ASP A 307
ILE A 255
ILE A 301
None
0.83A 3lzuB-1b4eA:
undetectable
3lzuB-1b4eA:
13.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1czi CHYMOSIN

(Bos taurus)
PF00026
(Asp)
5 ASP E 215
GLY E 217
VAL E 222
GLY E  76
ILE E 300
None
0.78A 3lzuB-1cziE:
6.6
3lzuB-1cziE:
17.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1czi CHYMOSIN

(Bos taurus)
PF00026
(Asp)
5 LEU E  30
ASP E  32
GLY E  34
ASP E  37
ILE E 120
None
0.83A 3lzuB-1cziE:
6.6
3lzuB-1cziE:
17.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fob BETA-1,4-GALACTANASE

(Aspergillus
aculeatus)
PF07745
(Glyco_hydro_53)
6 GLY A  40
ALA A  39
ASP A  38
VAL A 324
ILE A  44
ILE A 328
None
1.06A 3lzuB-1fobA:
undetectable
3lzuB-1fobA:
15.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fob BETA-1,4-GALACTANASE

(Aspergillus
aculeatus)
PF07745
(Glyco_hydro_53)
6 GLY A  40
ALA A  39
ASP A  38
VAL A 324
PRO A 299
ILE A 328
None
1.02A 3lzuB-1fobA:
undetectable
3lzuB-1fobA:
15.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gpe PROTEIN (GLUCOSE
OXIDASE)


(Penicillium
amagasakiense)
PF00732
(GMC_oxred_N)
PF05199
(GMC_oxred_C)
5 LEU A 302
GLY A 294
ILE A  29
VAL A 257
ILE A 301
None
FAD  A 600 ( 3.8A)
None
None
None
0.85A 3lzuB-1gpeA:
undetectable
3lzuB-1gpeA:
10.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1hrd GLUTAMATE
DEHYDROGENASE


([Clostridium]
symbiosum)
PF00208
(ELFV_dehydrog)
PF02812
(ELFV_dehydrog_N)
6 GLY A 300
ALA A 296
ASP A 297
ASP A 294
VAL A 292
ILE A 266
None
1.40A 3lzuB-1hrdA:
undetectable
3lzuB-1hrdA:
14.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  48
PRO A  81
VAL A  82
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 (-4.1A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.97A 3lzuB-1hvcA:
13.6
3lzuB-1hvcA:
45.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
PRO A  81
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.8A)
1.34A 3lzuB-1hvcA:
13.6
3lzuB-1hvcA:
45.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  25
ALA A  28
ASP A  29
VAL A  32
GLY A  48
ILE A  84
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.4A)
A79  A 800 (-3.6A)
A79  A 800 (-3.6A)
0.98A 3lzuB-1hvcA:
13.6
3lzuB-1hvcA:
45.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.9A)
A79  A 800 ( 4.4A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 ( 3.9A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.72A 3lzuB-1hvcA:
13.6
3lzuB-1hvcA:
45.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.0A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 4.7A)
A79  A 800 ( 4.3A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.54A 3lzuB-1hvcA:
13.6
3lzuB-1hvcA:
45.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1j2b ARCHAEOSINE
TRNA-GUANINE
TRANSGLYCOSYLASE


(Pyrococcus
horikoshii)
PF01472
(PUA)
PF01702
(TGT)
PF14809
(TGT_C1)
PF14810
(TGT_C2)
5 ASP A 535
GLY A 537
ASP A 542
GLY A 449
PRO A 504
None
0.80A 3lzuB-1j2bA:
undetectable
3lzuB-1j2bA:
11.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kae HISTIDINOL
DEHYDROGENASE


(Escherichia
coli)
PF00815
(Histidinol_dh)
5 GLY A 227
ALA A 228
ASP A 204
GLY A 196
ILE A 206
None
0.87A 3lzuB-1kaeA:
undetectable
3lzuB-1kaeA:
12.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1l3i PRECORRIN-6Y
METHYLTRANSFERASE/PU
TATIVE DECARBOXYLASE


(Methanothermobacter
thermautotrophicus)
PF13847
(Methyltransf_31)
5 LEU A 136
GLY A 108
VAL A 179
GLY A  15
ILE A 135
None
SAH  A 801 (-3.4A)
None
SAH  A 801 ( 3.8A)
None
0.86A 3lzuB-1l3iA:
undetectable
3lzuB-1l3iA:
19.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1l5j ACONITATE HYDRATASE
2


(Escherichia
coli)
PF00330
(Aconitase)
PF06434
(Aconitase_2_N)
PF11791
(Aconitase_B_N)
5 GLY A 721
ALA A 720
GLY A 715
ILE A 714
ILE A 707
None
0.89A 3lzuB-1l5jA:
undetectable
3lzuB-1l5jA:
9.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1php 3-PHOSPHOGLYCERATE
KINASE


(Geobacillus
stearothermophilus)
PF00162
(PGK)
5 GLY A 195
ASP A 200
VAL A 204
GLY A 350
ILE A 193
ADP  A 396 (-3.3A)
None
None
ADP  A 396 (-3.6A)
None
0.83A 3lzuB-1phpA:
undetectable
3lzuB-1phpA:
16.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1pix GLUTACONYL-COA
DECARBOXYLASE A
SUBUNIT


(Acidaminococcus
fermentans)
PF01039
(Carboxyl_trans)
5 LEU A 146
GLY A 189
ALA A 211
GLY A 252
ILE A 187
None
0.83A 3lzuB-1pixA:
undetectable
3lzuB-1pixA:
11.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
None
0.72A 3lzuB-1q9pA:
9.7
3lzuB-1q9pA:
87.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
None
0.58A 3lzuB-1q9pA:
9.7
3lzuB-1q9pA:
87.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qvz YDR533C PROTEIN

(Saccharomyces
cerevisiae)
PF01965
(DJ-1_PfpI)
6 LEU A 156
GLY A 159
ALA A 196
ILE A 210
PRO A 141
ILE A 157
None
None
None
None
CSO  A 138 ( 4.3A)
None
1.39A 3lzuB-1qvzA:
undetectable
3lzuB-1qvzA:
21.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1s2t PHOSPHOENOLPYRUVATE
PHOSPHOMUTASE


(Mytilus edulis)
PF13714
(PEP_mutase)
5 LEU A  71
ALA A  32
GLY A  42
ILE A  23
VAL A 108
None
0.88A 3lzuB-1s2tA:
undetectable
3lzuB-1s2tA:
18.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1shz GUANINE
NUCLEOTIDE-BINDING
PROTEIN
GALPHA(13):GALPHA(I1
) CHIMERA


(Mus musculus;
Rattus
norvegicus)
PF00503
(G-alpha)
5 LEU A 152
ASP A 155
GLY A 111
VAL A 100
ILE A 158
None
0.91A 3lzuB-1shzA:
undetectable
3lzuB-1shzA:
15.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
ILE A  84
None
0.84A 3lzuB-1sivA:
18.8
3lzuB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
PRO A  81
ILE A  84
None
1.38A 3lzuB-1sivA:
18.8
3lzuB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.62A 3lzuB-1sivA:
18.8
3lzuB-1sivA:
50.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tjr BX1

(Zea mays)
PF00290
(Trp_syntA)
5 GLY A 307
ALA A 308
ASP A 309
VAL A 269
ILE A 303
None
0.85A 3lzuB-1tjrA:
undetectable
3lzuB-1tjrA:
19.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tlg POLYANDROCARPA
LECTIN


(Polyandrocarpa
misakiensis)
PF00059
(Lectin_C)
5 LEU A  81
GLY A  56
ALA A  57
ASP A  58
GLY A  72
None
0.85A 3lzuB-1tlgA:
undetectable
3lzuB-1tlgA:
16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1to3 PUTATIVE ALDOLASE
YIHT


(Salmonella
enterica)
PF01791
(DeoC)
6 LEU A 184
GLY A 188
ALA A 189
ASP A 190
VAL A 127
ILE A 158
None
0.92A 3lzuB-1to3A:
undetectable
3lzuB-1to3A:
19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1u2e 2-HYDROXY-6-KETONONA
-2,4-DIENEDIOIC ACID
HYDROLASE


(Escherichia
coli)
PF12697
(Abhydrolase_6)
5 LEU A 281
GLY A  61
ALA A  60
ILE A  54
VAL A 277
None
0.83A 3lzuB-1u2eA:
undetectable
3lzuB-1u2eA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1u3t ALCOHOL
DEHYDROGENASE ALPHA
CHAIN


(Homo sapiens)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
6 GLY A  71
ALA A  70
VAL A 169
PRO A 329
VAL A 328
ILE A  90
None
1.50A 3lzuB-1u3tA:
undetectable
3lzuB-1u3tA:
14.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1usy ATP
PHOSPHORIBOSYLTRANSF
ERASE REGULATORY
SUBUNIT


(Thermotoga
maritima)
PF13393
(tRNA-synt_His)
5 ALA C 251
VAL C 114
ILE C 238
VAL C 109
ILE C 113
None
0.68A 3lzuB-1usyC:
undetectable
3lzuB-1usyC:
16.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1v5f PYRUVATE OXIDASE

(Aerococcus
viridans)
PF00205
(TPP_enzyme_M)
PF02775
(TPP_enzyme_C)
PF02776
(TPP_enzyme_N)
5 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.87A 3lzuB-1v5fA:
undetectable
3lzuB-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1v5f PYRUVATE OXIDASE

(Aerococcus
viridans)
PF00205
(TPP_enzyme_M)
PF02775
(TPP_enzyme_C)
PF02776
(TPP_enzyme_N)
6 LEU A 276
GLY A 215
ALA A 214
VAL A 236
GLY A 222
ILE A 212
None
FAD  A1601 (-2.9A)
None
None
None
None
1.29A 3lzuB-1v5fA:
undetectable
3lzuB-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vj0 ALCOHOL
DEHYDROGENASE,
ZINC-CONTAINING


(Thermotoga
maritima)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 LEU A 223
GLY A 228
ALA A 229
ASP A 230
ILE A 202
None
0.83A 3lzuB-1vj0A:
undetectable
3lzuB-1vj0A:
14.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vr0 PROBABLE
2-PHOSPHOSULFOLACTAT
E PHOSPHATASE


(Clostridium
acetobutylicum)
PF04029
(2-ph_phosp)
6 LEU A  38
GLY A 121
ILE A 118
PRO A  47
VAL A  45
ILE A  34
None
1.40A 3lzuB-1vr0A:
undetectable
3lzuB-1vr0A:
18.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wac P2 PROTEIN

(Pseudomonas
virus phi6)
PF00680
(RdRP_1)
6 LEU A 252
GLY A  35
ALA A  36
PRO A 261
VAL A 260
ILE A 258
None
1.40A 3lzuB-1wacA:
undetectable
3lzuB-1wacA:
9.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wdt ELONGATION FACTOR G
HOMOLOG


(Thermus
thermophilus)
PF00009
(GTP_EFTU)
PF00679
(EFG_C)
PF03764
(EFG_IV)
PF14492
(EFG_II)
5 ALA A 237
VAL A 213
GLY A 231
VAL A 208
ILE A 212
None
0.86A 3lzuB-1wdtA:
undetectable
3lzuB-1wdtA:
9.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wl4 ACETYL-COENZYME A
ACETYLTRANSFERASE 2


(Homo sapiens)
PF00108
(Thiolase_N)
PF02803
(Thiolase_C)
6 LEU A  42
GLY A  76
ASP A  32
VAL A  37
VAL A 115
ILE A  38
None
1.49A 3lzuB-1wl4A:
undetectable
3lzuB-1wl4A:
13.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wsv AMINOMETHYLTRANSFERA
SE


(Homo sapiens)
PF01571
(GCV_T)
PF08669
(GCV_T_C)
5 LEU A 152
VAL A 192
GLY A 166
VAL A 207
ILE A 205
LEU  A 152 ( 0.6A)
VAL  A 192 ( 0.6A)
GLY  A 166 ( 0.0A)
VAL  A 207 ( 0.6A)
ILE  A 205 ( 0.4A)
0.81A 3lzuB-1wsvA:
undetectable
3lzuB-1wsvA:
14.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yr2 PROLYL
OLIGOPEPTIDASE


(Novosphingobium
capsulatum)
PF00326
(Peptidase_S9)
PF02897
(Peptidase_S9_N)
6 GLY A 539
ALA A 538
ASP A 537
GLY A 529
PRO A 475
VAL A 474
None
1.10A 3lzuB-1yr2A:
undetectable
3lzuB-1yr2A:
9.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yv9 HYDROLASE, HALOACID
DEHALOGENASE FAMILY


(Enterococcus
faecalis)
PF13242
(Hydrolase_like)
PF13344
(Hydrolase_6)
6 LEU A 104
GLY A  98
GLY A 121
ILE A  94
VAL A  91
ILE A 103
None
1.27A 3lzuB-1yv9A:
undetectable
3lzuB-1yv9A:
17.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2a2f EXOCYST COMPLEX
COMPONENT SEC15


(Drosophila
melanogaster)
PF04091
(Sec15)
6 LEU X 239
ALA X 185
ASP X 184
GLY X 190
ILE X 193
ILE X 242
None
1.38A 3lzuB-2a2fX:
undetectable
3lzuB-2a2fX:
14.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2b3x IRON-RESPONSIVE
ELEMENT BINDING
PROTEIN 1


(Homo sapiens)
PF00330
(Aconitase)
PF00694
(Aconitase_C)
6 LEU A 669
GLY A 672
ALA A 770
VAL A 795
GLY A 775
PRO A 787
None
1.16A 3lzuB-2b3xA:
undetectable
3lzuB-2b3xA:
6.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bih NITRATE REDUCTASE
[NADPH]


(Ogataea angusta)
PF00174
(Oxidored_molyb)
PF03404
(Mo-co_dimer)
5 LEU A 256
GLY A 178
ALA A 180
VAL A 107
ILE A 109
None
0.84A 3lzuB-2bihA:
undetectable
3lzuB-2bihA:
13.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bii NITRATE REDUCTASE
[NADPH]


(Ogataea angusta)
PF00174
(Oxidored_molyb)
PF03404
(Mo-co_dimer)
5 LEU A 256
GLY A 178
ALA A 180
VAL A 107
ILE A 109
None
0.77A 3lzuB-2biiA:
undetectable
3lzuB-2biiA:
15.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bkl PROLYL ENDOPEPTIDASE

(Myxococcus
xanthus)
PF00326
(Peptidase_S9)
PF02897
(Peptidase_S9_N)
6 GLY A 497
ALA A 496
ASP A 495
GLY A 487
PRO A 431
VAL A 430
None
1.12A 3lzuB-2bklA:
undetectable
3lzuB-2bklA:
10.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dph FORMALDEHYDE
DISMUTASE


(Pseudomonas
putida)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
6 GLY A 174
ALA A 201
VAL A 189
GLY A 296
ILE A 297
ILE A 191
None
1.45A 3lzuB-2dphA:
undetectable
3lzuB-2dphA:
15.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dws COPPER-CONTAINING
NITRITE REDUCTASE


(Rhodobacter
sphaeroides)
PF00394
(Cu-oxidase)
PF07732
(Cu-oxidase_3)
5 LEU A  90
GLY A 254
ALA A 255
GLY A 347
ILE A 250
None
0.90A 3lzuB-2dwsA:
undetectable
3lzuB-2dwsA:
14.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
0.49A 3lzuB-2fmbA:
14.9
3lzuB-2fmbA:
34.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
7 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  54
ILE A  89
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
0.86A 3lzuB-2fmbA:
14.9
3lzuB-2fmbA:
34.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2g28 PYRUVATE
DEHYDROGENASE E1
COMPONENT


(Escherichia
coli)
PF00456
(Transketolase_N)
5 LEU A 565
GLY A 573
PRO A 594
VAL A 516
ILE A 518
None
0.79A 3lzuB-2g28A:
undetectable
3lzuB-2g28A:
8.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2g4r MOLYBDOPTERIN
BIOSYNTHESIS MOG
PROTEIN


(Mycobacterium
tuberculosis)
PF00994
(MoCF_biosynth)
5 GLY A 115
ASP A  97
GLY A 118
ILE A 125
ILE A  99
None
TRS  A 301 (-2.8A)
None
None
None
0.81A 3lzuB-2g4rA:
undetectable
3lzuB-2g4rA:
22.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hc8 CATION-TRANSPORTING
ATPASE, P-TYPE


(Archaeoglobus
fulgidus)
PF00122
(E1-E2_ATPase)
5 ASP A 288
VAL A 290
ILE A 250
PRO A 258
VAL A 259
None
0.81A 3lzuB-2hc8A:
undetectable
3lzuB-2hc8A:
19.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2isq CYSTEINE SYNTHASE

(Arabidopsis
thaliana)
PF00291
(PALP)
5 GLY A 190
ALA A 189
GLY A 183
ILE A 180
PRO A 296
None
None
PLP  A 400 (-3.4A)
PLP  A 400 (-4.9A)
PLP  A 400 (-4.0A)
0.79A 3lzuB-2isqA:
undetectable
3lzuB-2isqA:
15.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2iss PYRIDOXAL
BIOSYNTHESIS LYASE
PDXS


(Thermotoga
maritima)
PF01680
(SOR_SNZ)
5 LEU A 224
GLY A 229
ALA A 230
ASP A 231
VAL A 158
None
0.84A 3lzuB-2issA:
undetectable
3lzuB-2issA:
14.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2mf2 MRNA INTERFERASE
MAZF


(Staphylococcus
aureus)
PF02452
(PemK_toxin)
6 LEU A 118
ASP A 115
ASP A 108
ASP A 109
GLY A  17
ILE A  40
None
1.28A 3lzuB-2mf2A:
undetectable
3lzuB-2mf2A:
19.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p3e DIAMINOPIMELATE
DECARBOXYLASE


(Aquifex
aeolicus)
PF00278
(Orn_DAP_Arg_deC)
PF02784
(Orn_Arg_deC_N)
5 ALA A 355
VAL A 371
GLY A 345
ILE A 308
ILE A 328
None
0.87A 3lzuB-2p3eA:
undetectable
3lzuB-2p3eA:
14.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ri6 2-HYDROXY-6-OXO-6-PH
ENYLHEXA-2,4-DIENOAT
E HYDROLASE


(Paraburkholderia
xenovorans)
PF12697
(Abhydrolase_6)
6 LEU A 283
GLY A  63
ALA A  62
GLY A  57
VAL A 279
ILE A 280
None
0.95A 3lzuB-2ri6A:
undetectable
3lzuB-2ri6A:
15.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
1.33A 3lzuB-2rkfA:
20.7
3lzuB-2rkfA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.9A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.8A)
AB1  A 501 (-3.5A)
AB1  A 501 (-4.2A)
AB1  A 501 ( 4.2A)
0.53A 3lzuB-2rkfA:
20.7
3lzuB-2rkfA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.9A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-4.2A)
AB1  A 501 ( 4.2A)
0.38A 3lzuB-2rkfA:
20.7
3lzuB-2rkfA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rsp RSV PROTEASE

(Rous sarcoma
virus)
PF00077
(RVP)
6 LEU A  35
ASP A  37
ALA A  40
ASP A  41
ILE A  71
ILE A 108
None
1.38A 3lzuB-2rspA:
12.7
3lzuB-2rspA:
33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rsp RSV PROTEASE

(Rous sarcoma
virus)
PF00077
(RVP)
6 LEU A  35
ASP A  37
GLY A  39
ALA A  40
ASP A  41
ILE A 108
None
0.48A 3lzuB-2rspA:
12.7
3lzuB-2rspA:
33.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vn8 RETICULON-4-INTERACT
ING PROTEIN 1


(Homo sapiens)
PF08240
(ADH_N)
PF13602
(ADH_zinc_N_2)
5 LEU A 243
GLY A 248
ALA A 249
ASP A 250
ASP A 251
None
0.67A 3lzuB-2vn8A:
undetectable
3lzuB-2vn8A:
16.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wsk GLYCOGEN DEBRANCHING
ENZYME


(Escherichia
coli)
PF00128
(Alpha-amylase)
PF02922
(CBM_48)
5 LEU A 188
GLY A 255
ALA A 254
ILE A 248
ILE A 185
None
0.77A 3lzuB-2wskA:
undetectable
3lzuB-2wskA:
8.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2x7i MEVALONATE KINASE

(Staphylococcus
aureus)
PF00288
(GHMP_kinases_N)
PF08544
(GHMP_kinases_C)
5 LEU A  15
ALA A 215
PRO A 154
VAL A  30
ILE A  28
None
0.90A 3lzuB-2x7iA:
undetectable
3lzuB-2x7iA:
16.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2y23 MYOMESIN

(Homo sapiens)
PF07679
(I-set)
5 ASP A1401
GLY A1409
ILE A1410
VAL A1428
ILE A1389
None
0.85A 3lzuB-2y23A:
undetectable
3lzuB-2y23A:
15.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z5x AMINE OXIDASE
[FLAVIN-CONTAINING]
A


(Homo sapiens)
PF01593
(Amino_oxidase)
5 LEU A 233
ALA A  29
VAL A 238
GLY A  22
ILE A  23
None
None
None
FAD  A 600 (-3.2A)
FAD  A 600 (-4.9A)
0.90A 3lzuB-2z5xA:
undetectable
3lzuB-2z5xA:
12.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2zxo SINGLE-STRANDED DNA
SPECIFIC EXONUCLEASE
RECJ


(Thermus
thermophilus)
PF01368
(DHH)
PF02272
(DHHA1)
5 LEU A  92
GLY A 187
ALA A 188
PRO A 207
ILE A  91
None
0.86A 3lzuB-2zxoA:
undetectable
3lzuB-2zxoA:
9.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3b8b CYSQ, SULFITE
SYNTHESIS PATHWAY
PROTEIN


(Bacteroides
thetaiotaomicron)
PF00459
(Inositol_P)
6 ALA A   6
ASP A   5
VAL A 112
GLY A  11
ILE A  14
ILE A 100
None
1.31A 3lzuB-3b8bA:
undetectable
3lzuB-3b8bA:
16.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3c4n UNCHARACTERIZED
PROTEIN DR_0571


(Deinococcus
radiodurans)
PF01266
(DAO)
5 LEU A 370
GLY A 200
VAL A  40
VAL A 230
ILE A 228
None
0.84A 3lzuB-3c4nA:
undetectable
3lzuB-3c4nA:
11.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3d5t MALATE DEHYDROGENASE

(Burkholderia
pseudomallei)
PF00056
(Ldh_1_N)
PF02866
(Ldh_1_C)
6 LEU A 165
ALA A 199
GLY A 203
PRO A 175
VAL A 176
ILE A 179
None
1.49A 3lzuB-3d5tA:
undetectable
3lzuB-3d5tA:
15.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dbg PUTATIVE CYTOCHROME
P450


(Streptomyces
coelicolor)
PF00067
(p450)
5 GLY A 359
ALA A 360
ASP A 361
PRO A  24
ILE A 356
None
0.85A 3lzuB-3dbgA:
undetectable
3lzuB-3dbgA:
10.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ecd SERINE
HYDROXYMETHYLTRANSFE
RASE 2


(Burkholderia
pseudomallei)
PF00464
(SHMT)
6 LEU A 295
GLY A 216
ALA A 215
PRO A 370
VAL A 294
ILE A 291
None
1.36A 3lzuB-3ecdA:
undetectable
3lzuB-3ecdA:
14.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3g7r PUTATIVE
TRANSCRIPTIONAL
REGULATOR


(Streptomyces
coelicolor)
PF00440
(TetR_N)
5 ALA A 167
VAL A  99
GLY A 186
VAL A  94
ILE A  98
None
None
None
None
EDO  A 960 ( 4.8A)
0.88A 3lzuB-3g7rA:
undetectable
3lzuB-3g7rA:
18.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gb0 PEPTIDASE T

(Bacillus cereus)
PF01546
(Peptidase_M20)
PF07687
(M20_dimer)
6 GLY A 105
ALA A 106
ASP A 107
GLY A 111
VAL A 353
ILE A 351
None
1.05A 3lzuB-3gb0A:
undetectable
3lzuB-3gb0A:
14.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gf7 GLUTACONYL-COA
DECARBOXYLASE
SUBUNIT A


([Clostridium]
symbiosum)
PF01039
(Carboxyl_trans)
6 LEU A 148
GLY A 191
ALA A 213
ASP A 212
GLY A 256
ILE A 189
None
1.16A 3lzuB-3gf7A:
undetectable
3lzuB-3gf7A:
11.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gve YFKN PROTEIN

(Bacillus
subtilis)
PF00149
(Metallophos)
5 GLY A 121
ALA A 122
ASP A 123
ILE A  89
ILE A 126
None
0.76A 3lzuB-3gveA:
undetectable
3lzuB-3gveA:
15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hdy UDP-GALACTOPYRANOSE
MUTASE


(Deinococcus
radiodurans)
PF03275
(GLF)
PF13450
(NAD_binding_8)
5 GLY A  38
ALA A  37
VAL A 237
VAL A  55
ILE A  57
FAD  A 450 (-3.3A)
None
None
None
None
0.88A 3lzuB-3hdyA:
undetectable
3lzuB-3hdyA:
12.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hh1 TETRAPYRROLE
METHYLASE FAMILY
PROTEIN


(Chlorobaculum
tepidum)
PF00590
(TP_methylase)
5 LEU A  79
GLY A 111
ALA A 110
VAL A  75
ILE A  76
None
0.90A 3lzuB-3hh1A:
undetectable
3lzuB-3hh1A:
22.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hhd FATTY ACID SYNTHASE

(Homo sapiens)
PF00109
(ketoacyl-synt)
PF00698
(Acyl_transf_1)
PF02801
(Ketoacyl-synt_C)
PF16197
(KAsynt_C_assoc)
6 LEU A 567
ALA A 590
ASP A 591
GLY A 579
ILE A 495
ILE A 564
None
1.33A 3lzuB-3hhdA:
undetectable
3lzuB-3hhdA:
7.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hur ALANINE RACEMASE

(Oenococcus oeni)
PF00842
(Ala_racemase_C)
PF01168
(Ala_racemase_N)
6 GLY A  87
ALA A  88
ASP A  93
ILE A  64
VAL A 124
ILE A 104
None
1.43A 3lzuB-3hurA:
undetectable
3lzuB-3hurA:
14.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i5g MYOSIN HEAVY CHAIN
ISOFORM A


(Doryteuthis
pealeii)
PF00063
(Myosin_head)
PF00612
(IQ)
PF02736
(Myosin_N)
6 GLY A 264
ALA A 265
ASP A 266
GLY A 460
ILE A 459
ILE A 224
None
1.14A 3lzuB-3i5gA:
undetectable
3lzuB-3i5gA:
8.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3iru PHOSHONOACETALDEHYDE
HYDROLASE LIKE
PROTEIN


(Oleispira
antarctica)
PF13419
(HAD_2)
5 LEU A  29
GLY A  21
ALA A  20
GLY A  56
VAL A  32
None
0.76A 3lzuB-3iruA:
undetectable
3lzuB-3iruA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3j08 COPPER-EXPORTING
P-TYPE ATPASE A


(Archaeoglobus
fulgidus)
PF00122
(E1-E2_ATPase)
PF00702
(Hydrolase)
5 ASP A 288
VAL A 290
ILE A 250
PRO A 258
VAL A 259
None
0.87A 3lzuB-3j08A:
undetectable
3lzuB-3j08A:
10.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3j09 COPPER-EXPORTING
P-TYPE ATPASE A


(Archaeoglobus
fulgidus)
PF00122
(E1-E2_ATPase)
PF00403
(HMA)
PF00702
(Hydrolase)
5 ASP A 288
VAL A 290
ILE A 250
PRO A 258
VAL A 259
None
0.86A 3lzuB-3j09A:
undetectable
3lzuB-3j09A:
10.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jv7 ADH-A

(Rhodococcus
ruber)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 LEU A 211
GLY A 216
ALA A 217
ASP A 218
ILE A 190
None
0.66A 3lzuB-3jv7A:
undetectable
3lzuB-3jv7A:
14.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3khz PUTATIVE DIPEPTIDASE
SACOL1801


(Staphylococcus
aureus)
PF01546
(Peptidase_M20)
5 LEU A 130
GLY A  73
ALA A  72
GLY A  80
ILE A 127
None
0.88A 3lzuB-3khzA:
undetectable
3lzuB-3khzA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kkl PROBABLE CHAPERONE
PROTEIN HSP33


(Saccharomyces
cerevisiae)
no annotation 6 LEU A 156
GLY A 159
ALA A 196
ILE A 210
PRO A 141
ILE A 157
None
1.28A 3lzuB-3kklA:
undetectable
3lzuB-3kklA:
19.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lsc TRIAZINE HYDROLASE

(Paenarthrobacter
aurescens)
PF01979
(Amidohydro_1)
6 LEU A 383
ALA A 389
VAL A  33
ILE A  48
VAL A  35
ILE A  32
None
1.25A 3lzuB-3lscA:
undetectable
3lzuB-3lscA:
11.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mgl SULFATE PERMEASE
FAMILY PROTEIN


(Vibrio cholerae)
PF01740
(STAS)
5 LEU A 475
VAL A 532
GLY A 522
VAL A 505
ILE A 507
None
0.84A 3lzuB-3mglA:
undetectable
3lzuB-3mglA:
25.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
ALA A  28
ASP A  29
VAL A  32
GLY A  48
PRO A  81
ILE A  84
None
0.95A 3lzuB-3mwsA:
20.1
3lzuB-3mwsA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  30
GLY A  48
PRO A  81
ILE A  84
None
1.35A 3lzuB-3mwsA:
20.1
3lzuB-3mwsA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  25
ALA A  28
ASP A  30
PRO A  81
VAL A  82
ILE A  84
None
1.33A 3lzuB-3mwsA:
20.1
3lzuB-3mwsA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
None
0.21A 3lzuB-3mwsA:
20.1
3lzuB-3mwsA:
78.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o8l 6-PHOSPHOFRUCTOKINAS
E, MUSCLE TYPE


(Oryctolagus
cuniculus)
PF00365
(PFK)
6 GLY A 224
ALA A 225
ASP A 226
ILE A 192
VAL A 207
ILE A 261
PO4  A 767 ( 4.6A)
None
None
None
None
None
1.19A 3lzuB-3o8lA:
undetectable
3lzuB-3o8lA:
9.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o8o 6-PHOSPHOFRUCTOKINAS
E SUBUNIT ALPHA


(Saccharomyces
cerevisiae)
PF00365
(PFK)
6 GLY A 414
ALA A 415
ASP A 416
ILE A 382
VAL A 397
ILE A 452
None
1.29A 3lzuB-3o8oA:
undetectable
3lzuB-3o8oA:
8.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pv2 DEGQ

(Legionella
fallonii)
PF13180
(PDZ_2)
PF13365
(Trypsin_2)
5 GLY A 287
ALA A 286
VAL A 321
GLY A 249
ILE A 323
None
0.84A 3lzuB-3pv2A:
undetectable
3lzuB-3pv2A:
12.36